Endoscopic treatment of early-stage lung cancer

Francis Sheski, Praveen N. Mathur

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Background: Disease-free survival after surgical resection of lung carcinoma in situ has been reported as over 90%. After resection of stage IA non-small cell lung cancer, survival at 5 years is approximately 60% to 70%. If endoscopic or bronchoscopic treatments of early-stage lung cancer can provide similar disease-free survival with less perioperative mortality, morbidity, and cost, then they may be alternative front-line therapies. Methods: The authors review early-stage lung cancer detection by fluorescence bronchoscopy and the potential treatment of this disease by endoscopic techniques (photodynamic therapy, brachytherapy, Nd:YAG laser, electrocautery, and cryotherapy). Results: Several reports have noted improved outcomes using endoscopic therapies for early-stage lung cancer, but insufficient data preclude firm conclusions regarding the role of fluorescence bronchoscopy, endobronchial brachytherapy, or electrocautery in early-stage lung cancer. Other than resection, photodynamic therapy may represent the best approach at this time. The principal indication for laser bronchoscopy is palliation of central airway obstruction. Conclusions: The identification of early-stage lung cancer provides no advantage if we have little to offer the patient short of traditional therapy. The value of newer treatment techniques and methods requires verification.

Original languageEnglish
Pages (from-to)35-44
Number of pages10
JournalCancer Control
Volume7
Issue number1
StatePublished - 2000

Fingerprint

Lung Neoplasms
Bronchoscopy
Electrocoagulation
Brachytherapy
Photochemotherapy
Disease-Free Survival
Therapeutics
Fluorescence
Cryotherapy
Carcinoma in Situ
Solid-State Lasers
Airway Obstruction
Non-Small Cell Lung Carcinoma
Lasers
Morbidity
Costs and Cost Analysis
Lung
Survival
Mortality

ASJC Scopus subject areas

  • Oncology

Cite this

Endoscopic treatment of early-stage lung cancer. / Sheski, Francis; Mathur, Praveen N.

In: Cancer Control, Vol. 7, No. 1, 2000, p. 35-44.

Research output: Contribution to journalArticle

Sheski, F & Mathur, PN 2000, 'Endoscopic treatment of early-stage lung cancer', Cancer Control, vol. 7, no. 1, pp. 35-44.
Sheski, Francis ; Mathur, Praveen N. / Endoscopic treatment of early-stage lung cancer. In: Cancer Control. 2000 ; Vol. 7, No. 1. pp. 35-44.
@article{5716808e82d3465980dc4072b6ed8e89,
title = "Endoscopic treatment of early-stage lung cancer",
abstract = "Background: Disease-free survival after surgical resection of lung carcinoma in situ has been reported as over 90{\%}. After resection of stage IA non-small cell lung cancer, survival at 5 years is approximately 60{\%} to 70{\%}. If endoscopic or bronchoscopic treatments of early-stage lung cancer can provide similar disease-free survival with less perioperative mortality, morbidity, and cost, then they may be alternative front-line therapies. Methods: The authors review early-stage lung cancer detection by fluorescence bronchoscopy and the potential treatment of this disease by endoscopic techniques (photodynamic therapy, brachytherapy, Nd:YAG laser, electrocautery, and cryotherapy). Results: Several reports have noted improved outcomes using endoscopic therapies for early-stage lung cancer, but insufficient data preclude firm conclusions regarding the role of fluorescence bronchoscopy, endobronchial brachytherapy, or electrocautery in early-stage lung cancer. Other than resection, photodynamic therapy may represent the best approach at this time. The principal indication for laser bronchoscopy is palliation of central airway obstruction. Conclusions: The identification of early-stage lung cancer provides no advantage if we have little to offer the patient short of traditional therapy. The value of newer treatment techniques and methods requires verification.",
author = "Francis Sheski and Mathur, {Praveen N.}",
year = "2000",
language = "English",
volume = "7",
pages = "35--44",
journal = "Cancer Control",
issn = "1073-2748",
publisher = "H. Lee Moffitt Cancer Center and Research Institute",
number = "1",

}

TY - JOUR

T1 - Endoscopic treatment of early-stage lung cancer

AU - Sheski, Francis

AU - Mathur, Praveen N.

PY - 2000

Y1 - 2000

N2 - Background: Disease-free survival after surgical resection of lung carcinoma in situ has been reported as over 90%. After resection of stage IA non-small cell lung cancer, survival at 5 years is approximately 60% to 70%. If endoscopic or bronchoscopic treatments of early-stage lung cancer can provide similar disease-free survival with less perioperative mortality, morbidity, and cost, then they may be alternative front-line therapies. Methods: The authors review early-stage lung cancer detection by fluorescence bronchoscopy and the potential treatment of this disease by endoscopic techniques (photodynamic therapy, brachytherapy, Nd:YAG laser, electrocautery, and cryotherapy). Results: Several reports have noted improved outcomes using endoscopic therapies for early-stage lung cancer, but insufficient data preclude firm conclusions regarding the role of fluorescence bronchoscopy, endobronchial brachytherapy, or electrocautery in early-stage lung cancer. Other than resection, photodynamic therapy may represent the best approach at this time. The principal indication for laser bronchoscopy is palliation of central airway obstruction. Conclusions: The identification of early-stage lung cancer provides no advantage if we have little to offer the patient short of traditional therapy. The value of newer treatment techniques and methods requires verification.

AB - Background: Disease-free survival after surgical resection of lung carcinoma in situ has been reported as over 90%. After resection of stage IA non-small cell lung cancer, survival at 5 years is approximately 60% to 70%. If endoscopic or bronchoscopic treatments of early-stage lung cancer can provide similar disease-free survival with less perioperative mortality, morbidity, and cost, then they may be alternative front-line therapies. Methods: The authors review early-stage lung cancer detection by fluorescence bronchoscopy and the potential treatment of this disease by endoscopic techniques (photodynamic therapy, brachytherapy, Nd:YAG laser, electrocautery, and cryotherapy). Results: Several reports have noted improved outcomes using endoscopic therapies for early-stage lung cancer, but insufficient data preclude firm conclusions regarding the role of fluorescence bronchoscopy, endobronchial brachytherapy, or electrocautery in early-stage lung cancer. Other than resection, photodynamic therapy may represent the best approach at this time. The principal indication for laser bronchoscopy is palliation of central airway obstruction. Conclusions: The identification of early-stage lung cancer provides no advantage if we have little to offer the patient short of traditional therapy. The value of newer treatment techniques and methods requires verification.

UR - http://www.scopus.com/inward/record.url?scp=0033984487&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033984487&partnerID=8YFLogxK

M3 - Article

VL - 7

SP - 35

EP - 44

JO - Cancer Control

JF - Cancer Control

SN - 1073-2748

IS - 1

ER -